Company news

MiMedx Group, Inc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

MiMedx Confirms Receipt of Director Nominations from Prescience Point Capital Management

April 15, 2021

MiMedx Awarded Amniotic Tissue Supplier Agreement with Premier® Inc.’s SURPASS™ Purchasing Program

March 29, 2021

MiMedx Announces Fourth Quarter and Full Year 2020 Financial and Operating Results

March 7, 2021

MiMedx Announces Appointment of Phyllis Gardner, M.D. to Board of Directors

March 7, 2021

MiMedx to Participate at Upcoming Investor Conferences

March 2, 2021

MiMedx to Host Fourth Quarter and Full Year 2020 Operating and Financial Results Conference Call on March 9

March 1, 2021

MiMedx to Participate at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

February 9, 2021

Reminder: MiMedx to Present at the 39th Annual J.P. Morgan Healthcare Conference

January 5, 2021

MiMedx to Participate at the H.C. Wainwright BioConnect 2021 Conference

January 3, 2021

MiMedx to Present at the 39th Annual J.P. Morgan Healthcare Conference

December 6, 2020

MiMedx Appoints Jack Howarth as Senior Vice President, Investor Relations

November 30, 2020

MiMedx To Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference

November 23, 2020

MiMedx To Host Virtual 2020 Annual Meeting of Shareholders on Friday, November 20

November 12, 2020

MiMedx To Present At Canaccord Genuity Virtual MedTech & Diagnostics Forum

November 11, 2020

MiMedx To Advance the Conversation of Study Bias in the Clinical Evaluation of Skin Substitutes in Chronic Wounds at SAWC FALL

November 3, 2020

MiMedx Announces Third Quarter 2020 Financial Results

November 3, 2020

MiMedx Shares to Commence Trading on Nasdaq on Wednesday, November 4, 2020

November 2, 2020

MiMedx Announces Largest U.S. Commercial Payor Will Provide Coverage for EpiFix in the Treatment of Diabetic Foot Ulcers

November 2, 2020

MiMedx Announces Relisting on Nasdaq

October 29, 2020

MiMedx to Host Third Quarter 2020 Financial Results Call on November 5

October 28, 2020

MiMedx Files Definitive Proxy Materials

October 14, 2020

MiMedx Concludes Enrollment for Phase 2B Study of Osteoarthritis (OA) of the Knee

September 20, 2020

MiMedx Announces Preliminary Third Quarter 2020 Net Sales

September 20, 2020

MiMedx Concludes Enrollment for Phase 3 Plantar Fasciitis Trial

September 16, 2020

MiMedx Launches EpiCord Expandable Placental Allograft as Addition to Market Leading Portfolio

September 13, 2020

MiMedx to Discuss Strategic Priorities at Upcoming Virtual 2019 Annual Meeting of Shareholders

August 23, 2020

MiMedx Welcomes Robert B. Stein, M.D., Ph.D., to Head Revitalized R&D Efforts

August 9, 2020

MiMedx Files Second Quarter 2020 Form 10-Q

August 3, 2020

MiMedx Adds Rohit Kashyap, Ph.D., to Leadership Team as Executive Vice President and Chief Commercial Officer

July 27, 2020

MiMedx Announces Filing of 2020 First Quarter Form 10-Q

July 5, 2020

MiMedx Announces Filing of 2019 Annual Report

July 5, 2020

MiMedx Announces Concurrent $150 Million Private Equity and Debt Financings

July 1, 2020

MiMedx Provides Update on Payment Protection Program Loan

May 7, 2020

MiMedx Announces Appointment of William L. Phelan as Chief Accounting Officer

May 4, 2020

MiMedx Announces Additional Access to Capital and Financing

April 20, 2020

MiMedx Announces Settlement of VA Pricing Investigation

April 5, 2020

MiMedx Names Peter M. Carlson as Chief Financial Officer

March 18, 2020

MiMedx Announces Filing of 2018 Annual Report

March 16, 2020

MiMedx Announces Addition of Peter M. Carlson

December 15, 2019

MiMedx Provides Update Regarding Timing of Restatement

December 11, 2019

MiMedx Announces Securities and Exchange Commission Settlement

November 25, 2019

← Newer news releases

Calls

The 5 newest of 24 calls. Every call is listed under its year.

Decks

The 5 newest of 62 decks. Every deck is listed under its year.